Managed Healthcare Executive August 30, 2024
Emergent BioSolutions is planning to donate 50,000 doses of the mpox vaccine to countries in Central Africa.
The FDA approved the expansion of Emergent BioSolutions’ smallpox vaccine (ACAM2000) to prevent mpox in light of the recent global emergency declared by World Health Organization’s (WHO), according to a news release published yesterday. Emergent BioSolutions will also donate 50,000 doses pending deployment to impacted countries in Central Africa.
“Mpox has progressed to become an uncontrolled epidemic in Africa — prompting the WHO to declare a second public health emergency of international concern — creating an enormous need to use all effective tools to extinguish it as a threat,” Amesh A. Adalja, M.D., FIDSA, a health security and emerging infectious diseases expert at...
Today's Sponsors
Today's Sponsor